The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits.
about
Mechanisms of drug resistance: daptomycin resistanceLipid somersaults: Uncovering the mechanisms of protein-mediated lipid flippingEssentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatisFrequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial PeptidesEvolving resistance among Gram-positive pathogenstRNA-dependent alanylation of diacylglycerol and phosphatidylglycerol in Corynebacterium glutamicumThe GraS Sensor in Staphylococcus aureus Mediates Resistance to Host Defense Peptides Differing in Mechanisms of Action.Bacterial strategies of resistance to antimicrobial peptides.Molecular determinants of bacterial sensitivity and resistance to mammalian Group IIA phospholipase A2.Mass spectrometry methods for predicting antibiotic resistance.Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.Aspartate tightens the anchoring of staphylococcal lipoproteins to the cytoplasmic membrane.Antimicrobial Peptides in Biomedical Device Manufacturing.Deciphering the tRNA-dependent lipid aminoacylation systems in bacteria: Novel components and structural advances.Salmonella Tol-Pal reduces outer-membrane glycerophopholipid levels for envelope homeostasis and survival during bacteremia.Mechanisms of Antibiotic Resistance.Streptococcal Lancefield polysaccharides are critical cell wall determinants for human Group IIA secreted phospholipase A2 to exert its bactericidal effects
P2860
Q26779944-1382C20D-0406-4C04-92B5-02B89D429D3AQ28395224-C30631F2-17ED-49A1-839D-CE687AF43FE7Q28552724-80D7265F-584D-46A8-A153-4ABB6F3433A5Q35860154-106331AA-85FF-4DB2-A666-D864C04B0B3CQ35999912-70DEE70E-EB50-45CF-88B4-8A7149058D5CQ36266308-D45FAA05-AEBC-46A9-842B-F8C9DA4F67B2Q36513442-827BA12C-235A-42AA-A835-9AFD39F9AA09Q36920921-CA95672E-11E7-4A12-8327-AA0296B579E3Q38529191-CB774C3E-247E-4FDF-84ED-7965B17EC1A9Q38867552-E7C2979D-3437-4E0F-B278-2BE8E2DD2886Q39000860-B725FB0B-7AE2-4436-A6A6-4F028FC279B4Q40049585-16082DBE-6FC9-427E-A785-49E69BF2066CQ41991862-A8651F55-ED90-4DA3-BC1B-AC64A497651EQ46319793-131BFC2E-23BF-46D7-AD07-9E0A662CB0CCQ53686632-930B0C9F-5829-420A-A981-3ECF8B01312FQ55387439-91AC9C94-E14E-4A0C-BA1B-D51DFBF67501Q57465697-F99E85BC-489B-4578-A50F-DCA2CBF1EEB0
P2860
The lipid-modifying multiple peptide resistance factor is an oligomer consisting of distinct interacting synthase and flippase subunits.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The lipid-modifying multiple p ...... ynthase and flippase subunits.
@en
type
label
The lipid-modifying multiple p ...... ynthase and flippase subunits.
@en
prefLabel
The lipid-modifying multiple p ...... ynthase and flippase subunits.
@en
P2093
P2860
P356
P1433
P1476
The lipid-modifying multiple p ...... synthase and flippase subunits
@en
P2093
Andreas Peschel
Bernhard Krismer
Christoph J Slavetinsky
Cordula Gekeler
Dirk Kraus
Samuel Wagner
Sebastian Kuhn
Simon Heilbronner
P2860
P356
10.1128/MBIO.02340-14
P577
2015-01-27T00:00:00Z